These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 8743538

  • 1. C-type natriuretic peptide in chronic renal failure and its action in humans.
    Igaki T, Itoh H, Suga S, Hama N, Ogawa Y, Komatsu Y, Mukoyama M, Sugawara A, Yoshimasa T, Tanaka I, Nakao K.
    Kidney Int Suppl; 1996 Jun; 55():S144-7. PubMed ID: 8743538
    [Abstract] [Full Text] [Related]

  • 2. Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients.
    Hama N, Itoh H, Shirakami G, Suga S, Komatsu Y, Yoshimasa T, Tanaka I, Mori K, Nakao K.
    Biochem Biophys Res Commun; 1994 Feb 15; 198(3):1177-82. PubMed ID: 8117275
    [Abstract] [Full Text] [Related]

  • 3. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
    Borgeson DD, Stevens TL, Heublein DM, Matsuda Y, Burnett JC.
    Clin Sci (Lond); 1998 Aug 15; 95(2):195-202. PubMed ID: 9680502
    [Abstract] [Full Text] [Related]

  • 4. Human C-type natriuretic peptide: effects on the haemodynamic and endocrine responses to angiotensin II.
    Cargill RI, Struthers AD, Lipworth BJ.
    Cardiovasc Res; 1995 Jan 15; 29(1):108-11. PubMed ID: 7895227
    [Abstract] [Full Text] [Related]

  • 5. Effects of intravenously administered C-type natriuretic peptide in humans: comparison with atrial natriuretic peptide.
    Igaki T, Itoh H, Suga SI, Hama N, Ogawa Y, Komatsu Y, Yamashita J, Doi K, Chun TH, Nakao K.
    Hypertens Res; 1998 Mar 15; 21(1):7-13. PubMed ID: 9582102
    [Abstract] [Full Text] [Related]

  • 6. Bolus injections of synthetic atrial natriuretic peptide in patients with chronic renal failure or nephrotic syndrome.
    Burnier M, Mooser V, Wauters JP, Marder HK, De Vane P, Nussberger J, Waeber B, Brunner HR.
    J Cardiovasc Pharmacol; 1989 May 15; 13(5):682-90. PubMed ID: 2472515
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Plasma concentrations of natriuretic peptides in patients on hemodialysis.
    Takahashi M, Nagake Y, Ichikawa H, Kawabata K, Nakazono H, Hirata K, Ogura T, Makino H.
    Res Commun Mol Pathol Pharmacol; 1996 Apr 15; 92(1):19-30. PubMed ID: 8733825
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Plasma brain natriuretic peptide and C-type natriuretic peptide in essential hypertension.
    Cheung BM, Brown MJ.
    J Hypertens; 1994 Apr 15; 12(4):449-54. PubMed ID: 8064169
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G, Lazzeri C, Pascale A, Sestini S, Bisi G, Sciagrà R, Vecchiarino S, Raggi VC, Barletta G, Laffi G, Gentilini P.
    Am J Gastroenterol; 1997 May 15; 92(5):852-7. PubMed ID: 9149200
    [Abstract] [Full Text] [Related]

  • 16. Plasma human brain natriuretic peptide in chronic renal failure.
    Akiba T, Tachibana K, Togashi K, Hiroe M, Marumo F.
    Clin Nephrol; 1995 Nov 15; 44 Suppl 1():S61-4. PubMed ID: 8608666
    [Abstract] [Full Text] [Related]

  • 17. C-type natriuretic peptide production by the human kidney is blunted in chronic heart failure.
    Kalra PR, Clague JR, Coats AJ, Anker SD, Poole-Wilson PA, Struthers AD.
    Clin Sci (Lond); 2009 Oct 02; 118(1):71-7. PubMed ID: 19450232
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer?
    Vesely DL.
    Clin Exp Pharmacol Physiol; 2006 Mar 02; 33(3):169-76. PubMed ID: 16487258
    [Abstract] [Full Text] [Related]

  • 20. C-type natriuretic peptide: the endothelial component of the natriuretic peptide system.
    Chen HH, Burnett JC.
    J Cardiovasc Pharmacol; 1998 Mar 02; 32 Suppl 3():S22-8. PubMed ID: 9883743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.